144 related articles for article (PubMed ID: 1290956)
1. The therapeutic potential of interleukin-1 and tumor necrosis factor on hematopoietic stem cells.
Moreb J; Zucali JR
Leuk Lymphoma; 1992 Nov; 8(4-5):267-75. PubMed ID: 1290956
[TBL] [Abstract][Full Text] [Related]
2. Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor cells from 4-hydroperoxycyclophosphamide by interleukin 1 beta and tumor necrosis factor.
Moreb J; Zucali JR; Zhang Y; Colvin MO; Gross MA
Cancer Res; 1992 Apr; 52(7):1770-4. PubMed ID: 1551107
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow cells.
Moreb JS; Turner C; Sreerama L; Zucali JR; Sladek NE; Schweder M
Leuk Lymphoma; 1995 Dec; 20(1-2):77-84. PubMed ID: 8750626
[TBL] [Abstract][Full Text] [Related]
4. Radioprotection and therapy of radiation injury with cytokines.
Neta R
Prog Clin Biol Res; 1990; 352():471-8. PubMed ID: 2205873
[TBL] [Abstract][Full Text] [Related]
5. Protection of cells capable of reconstituting long-term bone marrow stromal cultures from 4-hydroperoxycyclophosphamide by interleukin 1 and tumor necrosis factor.
Zucali JR; Moreb J; Bain C
Exp Hematol; 1992 Sep; 20(8):969-73. PubMed ID: 1505642
[TBL] [Abstract][Full Text] [Related]
6. Protection of hematopoietic progenitors from ultraviolet C by interleukin-1 and tumor necrosis factor-alpha.
Moreb JS; Safah H; Chen M
J Interferon Cytokine Res; 1997 Jul; 17(7):395-400. PubMed ID: 9243371
[TBL] [Abstract][Full Text] [Related]
7. The effects of tumor necrosis factor-alpha on early human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide.
Moreb J; Zucali JR; Rueth S
Blood; 1990 Aug; 76(4):681-9. PubMed ID: 2383651
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-1 and TNF-alpha on early progenitor cells: implications for bone marrow purging.
Zucali J; Moreb J; Weiner R
Bone Marrow Transplant; 1991; 7 Suppl 2():140. PubMed ID: 1878682
[No Abstract] [Full Text] [Related]
9. Cytokine protection of hematopoietic stem cells.
Zucali JR; Suresh A; Tung F; Eastgate J; Nick H; Moreb J
Prog Clin Biol Res; 1994; 389():207-16. PubMed ID: 7700904
[No Abstract] [Full Text] [Related]
10. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
Nara N
Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow.
Dalmau SR; Freitas CS; Tabak DG
Bone Marrow Transplant; 1993 Dec; 12(6):551-63. PubMed ID: 8136738
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects.
Urbaschek R; Urbaschek B
Rev Infect Dis; 1987; 9 Suppl 5():S607-15. PubMed ID: 3317753
[TBL] [Abstract][Full Text] [Related]
14. A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1.
Eastgate J; Moreb J; Nick HS; Suzuki K; Taniguchi N; Zucali JR
Blood; 1993 Feb; 81(3):639-46. PubMed ID: 8427959
[TBL] [Abstract][Full Text] [Related]
15. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
Neta R; Oppenheim JJ; Douches SD
J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.
Moreb J; Zucali JR; Gross MA; Weiner RS
J Immunol; 1989 Mar; 142(6):1937-42. PubMed ID: 2784143
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic effects and mechanisms of Fufang e׳jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice.
Liu M; Tan H; Zhang X; Liu Z; Cheng Y; Wang D; Wang F
J Ethnopharmacol; 2014 Mar; 152(3):575-84. PubMed ID: 24534527
[TBL] [Abstract][Full Text] [Related]
18. The effects of interleukin-1 beta and tumor necrosis factor-alpha on in vitro colony formation by human hematopoietic progenitor cells exposed to doxorubicin or hydroquinone.
Colinas RJ; Burkart PT; Lawrence DA
Exp Hematol; 1995 Nov; 23(12):1247-55. PubMed ID: 7589278
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of radiation injury to human hematopoietic stem cells with tumor necrosis factor-alpha.
Karkanitsa LV; Komarovskaya ME; Krivenko SI
Stem Cells; 1997; 15 Suppl 2():95-102. PubMed ID: 9368291
[TBL] [Abstract][Full Text] [Related]
20. The in vivo effect of recombinant human interleukin-1 receptor antagonist on spleen colony forming cells after radiation induced myelosuppression.
Milenkovíc P; Ivanovíc Z; Stosić-Grujicić S
Eur Cytokine Netw; 1995; 6(3):177-80. PubMed ID: 8589274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
